Abstract
Heat shock protein 60 (HSP60, HSPD1) is a “chaperonin” that facilitates folding of nascent proteins into proper conformations (1). It is thought to play a critical role in the assembly, folding, and transport of proteins in the mitochondria. HSP60 also interacts with nascent cellular proteins to prevent their denaturation under heat stress (2). The HSP60 gene sequence is known and is highly conserved (3). Expression of the HSP60 gene has been associated with cisplatin resistance in several preclinical model systems and in ovarian carcinoma patients (1-6); we quantitated HSP60 mRNA expression in preclinical human ovarian and bladder carcinoma models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Craig, E. A., Gambill, B. D., and Nelson, R. J. (1993) Heat shock proteins: molecular chaperones of protein biogenesis. Microbiol. Rev. 57, 402–414.
Martin, J., Horwich, A. L., and Hartl, F. U. (1992) Prevention of protein denaturation under heat stress by the chaperonin Hsp60. Science 258, 995–998.
Venner, T. J., Singh, B., and Gupta, R. S. (1990) Nucleotide sequences and novel structural features of human and Chinese hamster hsp60 (chaperonin) gene families. DNA Cell Biol. 9, 545–552.
Enns, R. E., Hom, D. K., Thiebaut, F., and Howell, S. B. (1991) An amplified mitochondrial chaperonin gene causes resistance to cisplatin in human ovarian tumor cells. Proc. Amer. Assoc. Cancer Res. 32, 2088–2090 (abstract).
Kimura, E., Enns, R. E., Alcaraz, J. E., Arboleda, J., Slamon, D. J., and Howell, S. B. (1993) Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat shock protein HSP-60. J. Clin. Oncol. 11, 891–898.
Shen, D-W., Pastan, I., and Gottesman, M. (1994) A 52 kD protein is overexpressed in cisplatin-resistant human liver carcinoma cells and in cisplatin-resistant mouse cells after DNA-mediated transformation. Proc. Amer. Assoc. Cancer Res. 35, 2630 (abstract).
Gause, W. and Adamovicz, J. (1994) The use of PCR to quantitate gene expression. PCR Meth. Applicat. 3, s123–s135.
Behrens, B. C., Hamilton, T. C., and Masuda, H. (1987) Characterization of a cis-diamminedi-chloroplatinim (II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res. 47, 414–418.
Glavy, J., Pendyala, L., Creaven, P. J., Perez, R., Zdanowicz, J., and Elakawi, Z. (1994) Isolation and preliminary characterization of oxaliplatin resistant A2780 ovarian carcinoma sublines. Proc. Amer. Assoc. Cancer Res. 35, 2590 (abstract).
Russell, P. J., Raghavan, D., Gregory, P., Phillips, J., Wills, E. J., Jelbart, M., et al. (1986) Bladder cancer xenografts: a model of tumor cell heterogeneity. Cancer Res. 46, 2035–2040.
Chomczynski, P. (1993) A reagent for the single-step simultaneous isolation of RNA, DNA, and proteins from cell and tissue samples. Biotechniques 15, 532–536.
Warren, W., Wheat, T., and Knudsen, P. (1991) Rapid analysis and quantitation of PCR products by high-performance liquid chromatography. Biotechniques 11, 250–255.
D’Aquila, R. T., Bechtel, L. J., Videler, J. A., Eron, J. J., Gorczyza, P., and Kaplan, J. C. (1991) Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucl. Acids Res. 19, 3749.
Sparkman, D. R. (1992) Paraffin wax as a vapor barrier for the PCR. PCR Meth. Appl. 2, 180,181.
Bell, D. A. and DeMarini, D. (1991) Excessive cycling converts PCR products to random-length higher molecular weight fragments. Nucl. Acids Res. 19, 5079.
El-akawi, Z., Abu-hadid, M., Perez, R., Glavy, J., Zdanowicz, J., Creaven, P. J., et al. (1996) Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells. Cancer Lett. 105, 5–14.
Abu-hadid, M., Wilkes, J. D., Elakawi, Z., Pendyala, L., and Perez, R. P. (1997) Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines. Cancer Lett. 119, 63–70.
Enger, O. (1996) Use of the fluorescent dye PicoGreen for quantitation of PCR products after agar-ose gel electrophoresis. Biotechniques 21, 372–374.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Perez, R.P., Pendyala, L., Elakawi, Z., Abu-hadid, M. (2000). RT-PCR Quantitation of HSP60 mRNA Expression. In: Bartlett, J.M.S. (eds) Ovarian Cancer. Methods in Molecular Medicine™, vol 39. Humana Press. https://doi.org/10.1385/1-59259-071-3:439
Download citation
DOI: https://doi.org/10.1385/1-59259-071-3:439
Publisher Name: Humana Press
Print ISBN: 978-0-89603-583-6
Online ISBN: 978-1-59259-071-1
eBook Packages: Springer Protocols